HomeENTO • NASDAQ
add
Entero Therapeutics Inc
Previous close
$0.38
Day range
$0.36 - $0.39
Year range
$0.19 - $3.16
Market cap
1.81M USD
Avg Volume
969.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 163.48K | -95.60% |
Total assets | 85.41M | 1,140.84% |
Total liabilities | 27.61M | 741.55% |
Total equity | 57.80M | — |
Shares outstanding | 4.77M | — |
Price to book | -0.46 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Headquarters
Website
Employees
2
